Addex Therapeutics Ltd
ADXN
$9.00
$0.19172.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.46M | 7.57M | 5.72M | 4.52M | -12.70M |
| Total Depreciation and Amortization | 215.70K | 216.70K | 192.90K | 134.30K | 13.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.90M | -12.52M | -12.60M | -13.12M | 2.46M |
| Change in Net Operating Assets | -1.98M | -1.32M | -28.00K | -351.40K | 1.39M |
| Cash from Operations | -4.20M | -6.05M | -6.72M | -8.81M | -8.83M |
| Capital Expenditure | -1.50K | -1.50K | -2.90K | -2.20K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.14M | 5.14M | 5.16M | 5.16M | -- |
| Cash from Investing | 5.14M | 5.14M | 5.15M | 5.16M | -5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.80K | -73.70K | -141.00K | -210.90K | -234.50K |
| Issuance of Common Stock | 4.50K | 241.00K | 256.10K | 253.90K | 1.41M |
| Repurchase of Common Stock | -21.20K | -25.70K | -29.00K | -49.40K | -43.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 63.90K | -36.60K | -37.80K | -133.80K | 3.27M |
| Cash from Financing | 42.90K | 122.10K | 58.20K | -155.10K | 4.90M |
| Foreign Exchange rate Adjustments | -16.00K | 113.40K | -157.70K | -88.50K | -256.10K |
| Miscellaneous Cash Flow Adjustments | 338.20K | -11.60K | -11.60K | -11.60K | -349.80K |
| Net Change in Cash | 1.30M | -686.30K | -1.68M | -3.91M | -4.55M |